Please see the Activity URL for more information on pricing and registration options.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 1.25 credits
MOC types
ABPATH — Lifelong LearningUp to 1.25 points
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Pricing
$5 – $208 per course
typical $59 · based on 120 courses listed here
Collected from the provider’s public pages · source
Specialties served/covered
- Anatomic & Clinical Pathology
- Blood Banking & Transfusion Medicine
- Clinical Informatics
- Cytopathology
- Dermatopathology
- Forensic Pathology
- General Surgery
- Head & Neck Surgery
- Hematology
- Hematopathology
- Medical Leadership & Administration
- Medical Microbiology
- Molecular Genetic Pathology
- Nephrology
- Neuropathology
- Obstetrics & Gynecology
- Practice Management & Ethics
- Urology
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Medical Subspecialties
- Ob/Gyn
- Oncology & Hematology
- Pathology & Lab
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
- Enduring / On-demand
- Credit · Up to 1.25 credits
- MOC · Up to 1.25 points
- Paid · this provider typically $45–70
-
ReleasedMay 18, 2026
-
Last day to claim creditMay 18, 2029 3 years left
-
College of American Pathologists 2023 CPIP-L Case 12: Hematology A Contemporary Approach to Lymphocytosis
-
College of American Pathologists 2024 CPIP-I Case 9: Hematology A Diagnostic Approach to Hemoglobinopathies
-
College of American Pathologists 2025 CPIP-C Case 3: Hematology Dealing With Hematologic Pleural Effusions: What Not to Miss
-
M3 IME B.V +1 Future Directions in Multiple Myeloma. The Impact of CELMoDs, MRD as a Clinical Endpoint, and the Importance of Shared Decision-Making
-
Blood and Marrow Transplant Information Network +1 Rising to the Graft-versus-Host Challenge: Progress in Managing GVHD & Post-HCT Outcomes Across Hematologic Cancers
-
Medscape, LLC 18th Annual Hematologic Malignancies Demystified, Session II
